MANAJEMEN AKTIF PERSALINAN KALA TIGA
Abstract
Abstrak. Perdarahan pasca persalinan (PPP) sampai saat ini masih merupakan penyebab utama kematian ibu di seluruh dunia. Sebagian besar kasus PPP terjadi selama persalinan kala tiga. Pada masa sebelumnya, kala tiga (pengeluaran plasenta) ditangani secara pasif dengan menunggu tanda-tanda lepasnya plasenta tanpa penggunaan uterotonika ataupun penegangan tali pusat terkendali. Dalam manajemen aktif, plasenta dilahirkan secara aktif dengan memberikan oksitosin 10 IU segera setelah bayi lahir, melakukan penegangan tali pusat terkendali (controlled-cord traction) dan masase uterus setelah pelepasan plasenta. Strategi ini diyakini akan menurunkan perdarahan pasca persalinan dan mempersingkat kala tiga.Tulisan ini bertujuan untuk membandingkan dua manajemen dalam menangani persalinan kala tiga dengan hasil akhir berupa penurunan kejadian perdarahan pasca persalinan.
Abstract. Postpartum hemorrhage is one of the most common causes of maternal mortality and morbidity worldwide. Most of postpartum hemorrhage cases occurred in the third stage of labor. In the old days the third stage of labor manage expectantly or physiologic management consists of delivery of the placenta without the use of uterotonic agents, cord clamping, or cord traction. Active management generally consists administration of a prophylactic oxytocin 10 IU up on delivery of the baby followed by controlled cord traction of umbilical cord, and uterine massege afterward. This strategy will decrease postpartum hemorrhage and shorten third stage. This paper try to compare active versus expectant management of the third stage of labor in reducing post partum hemorrhage.
Keywords
References
WHO. Global estimates of maternal mortality for 1995 : results of an in-depth review, analysis and estimation strategy [statement]. Geneva : WHO. 2001.
Li, Xi. The postpartum period : the key to maternal mortality. Int J Ginaecol Obstet. 1996. 54 : 1-10.
WHO. Managing Complications in Pregnancy and Childbirth : A Guide for Midwives and Doctors. Geneva : WHO. 2000.
Cunningham, G. Williams Obstetrics. 20th ed. Stamford, Connecticut : Appleton & Lange. 1997.
Stones, R.W. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol. 1993. 48 : 15-18.
Akins, S. Postpartum hemorrhage : a 90s approach to an age-old problem. J Nurse Midwifery. 1994. 39 (2), Supplement : 123S-134S.
Bulgaho, A. Misoprostol for prevention of postpartum hemorrhage. Int J Ginaecol Obstet. 2001. 73 : 1-6.
Prendiville, W.J. Active versus expectant management in the third stage of labour (Cochrane Review, March 9, 2000). In : The Cochrane Library. Issue 4. 2001. Oxford : Update Software, Ltd.
Begley, C. A comparison of ‘active’ and ‘physiological’ management of the third stage of labour. Midwifery. 1990. 6 : 3-17.
Khan, G. Q. Controlled cord traction versus minimal intervention techniques in delivery of the placenta : a randomized controlled trial. Am J Obstet Gynecol. 1997. 177 : 770-774.
Prendiville, WJ. The Bristol third stage trial : active versus physiological management of the third stage of labour. BMJ. 1998. 297 : 1295-1300.
Roger J. Wood J. McCandish R. Ayers S, Truesdale A and Elbourne D. Active versus expectant management of third stage of labour : the Hinchingbrooke randomised controlled trial. Lancet. 1998. 351 : 693-699.
Poeschmann, R.P. A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour. Br J Obstet Gynaecol. 1991. 98 : 528-530.
Nordstrom, L. Routine oxytocin in the third stage of labour : A placebo-controlled randomised trial. Br J Obstet Gynaecol. 1997. 104 : 781-786.
McDonald, S. Prophylactic syntometrine versus oksitosin for delivery of the placenta (Cochrane Review). In : The Cochrane Library, Issue 4, 2001. Oxford : Update Software. Ltd.
Gülmezoglu, A. M. Prostaglandins for prevention of postpartum hemorrhage (Cochrane Review). In : The Cochrane Library, Issue 2, 2001. Oxford : Update Software, Ltd.
Gülmezoglu, A.M. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet. 2001. 358(9283) : 689-695.
Darney, P. D. Misoprostol : a boon to safe motherhood or not? [commentary]. Lancet. 2001. 358 (9283) : 682-683.
Gyte, G. Evaluation of the meta-analyses on the effects, on both mother and baby, of the various components of ‘active’ management of the third stage of labour. Midwifery. 1994. 10 : 183-199.
WHO. Reduction of Maternal Mortality: A Joint WHO/UN.PA/UNICE./World Bank Statement. Geneva : WHO. 1999.
PATH, World Health Organization/ Indonesia, and Ministry of Health/ Indonesia. Oksitosin in Pre-filled Uniject™ Injection Devices for Management of Third Stage of Labor : An Introductory Trial in Lombok, Indonesia Report. Seattle, Washington : PATH. 2001.